Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr172.00 DKK
Change Today +0.50 / 0.29%
Volume 20.0K
AMBUB On Other Exchanges
Symbol
Exchange
Copenhagen
As of 11:07 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

ambu a/s-b (AMBUB) Snapshot

Open
kr168.00
Previous Close
kr171.50
Day High
kr175.00
Day Low
kr167.50
52 Week High
05/13/15 - kr200.00
52 Week Low
10/16/14 - kr90.50
Market Cap
7.4B
Average Volume 10 Days
24.9K
EPS TTM
kr3.88
Shares Outstanding
41.4M
EX-Date
12/18/14
P/E TM
44.3x
Dividend
kr0.94
Dividend Yield
0.55%
Current Stock Chart for AMBU A/S-B (AMBUB)

Related News

No related news articles were found.

ambu a/s-b (AMBUB) Related Businessweek News

No Related Businessweek News Found

ambu a/s-b (AMBUB) Details

Ambu A/S provides healthcare solutions in anesthesia, patient monitoring and diagnostics, and emergency care fields worldwide. The company offers anesthesia products, including laryngeal masks, ventilation bags, face masks for artificial ventilation, scopes for visualization, anesthesia tubes, and pumps for palliative care; patient monitoring and diagnostics products, such as single-use electrodes for neurological and cardiological examinations, and tubes and needles; emergency care products comprising neck collars, manikins, and other equipment for first-aid training; conductive adhesive gels for use in the production of skin-contacting biomedical electrodes; and single-use videoscopes. The company serves hospitals, clinics, rescue services and sleep laboratories, aid organizations, and the armed forces. It sells and exports its products through direct sales and distributors. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

2,350 Employees
Last Reported Date: 05/6/15
Founded in 1937

ambu a/s-b (AMBUB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ambu a/s-b (AMBUB) Key Developments

Ambu Appoints Carsten Buhl as Executive Vice President (Chief Commercial Officer), Effective from August 03, 2015

Ambu appointed Carsten Buhl as Executive Vice President (Chief Commercial Officer). He will be responsible for Ambu's sales and marketing across the organisation in Europe, USA and Asia-Pacific. Carsten Buhl has 13 years of experience from the GN Store Nord corporation with his latest position being Senior Vice President, Europe Sales & Strategic Accounts at GN ReSound. Effective from August 03, 2015.

Ambu A/S Announces Unaudited Earnings Results for Second Quarter and Six Months Ended March 31, 2015; Provides Outlook for the Fiscal Year 2015

Ambu A/S announced unaudited earnings results for second quarter and six months ended March 31, 2015. For the quarter, the company reported revenue of DKK 483 million, profit before interest, tax, depreciation and amortisation (EBITDA) of DKK 72 million, operating profit (EBIT) of DKK 48 million, profit before tax of DKK 77 million, net profit for the period of DKK 58 million or DKK 1.18 diluted earnings per share, cash flows from operating activities of DKK 27 million compared to the revenue of DKK 403 million, profit before interest, tax, depreciation and amortisation (EBITDA) of DKK 68 million, operating profit (EBIT) of DKK 47 million, profit before tax of DKK 41 million, net profit for the period of DKK 30 million or DKK 0.62 diluted earnings per share, cash flows from operating activities of DKK 37 million for the same quarter a year ago. For the year to date, the company reported revenue of DKK 871 million, profit before interest, tax, depreciation and amortisation (EBITDA) of DKK 111 million, operating profit (EBIT) of DKK 63 million, profit before tax of DKK 88 million, net profit for the period of DKK 66 million or DKK 1.35 diluted earnings per share, cash flows from operating activities of DKK 11 million compared to the revenue of DKK 745 million, profit before interest, tax, depreciation and amortisation (EBITDA) of DKK 103 million, operating profit (EBIT) of DKK 63 million, profit before tax of DKK 45 million, net profit for the period of DKK 33 million cash flows from operating activities of DKK 57 million for the same period a year ago. At the end of March 2015, The company announced that financial net debt totaled DKK 832 million against DKK 729 million for the same period a year ago. The outlook for fiscal year 2015 is adjusted compared to the outlook announced in the interim report for first quarter 2015. The outlook is now of growth of approx. 8%-8.5% as opposed to 7%-8% in local currencies, an EBIT margin of approx. 12% as opposed to 12.5% and free cash flows before earn-out payments of approx. DKK 110 million -120 million as opposed to DKK 130 million -140 million.

Ambu A/S, Q2 2015 Earnings Call, May 06, 2015

Ambu A/S, Q2 2015 Earnings Call, May 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMBUB:DC kr172.00 DKK +0.50

AMBUB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Repro-Med Systems Inc $0.39 USD -0.0149
View Industry Companies
 

Industry Analysis

AMBUB

Industry Average

Valuation AMBUB Industry Range
Price/Earnings 47.0x
Price/Sales 4.9x
Price/Book 8.6x
Price/Cash Flow 39.9x
TEV/Sales 3.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMBU A/S-B, please visit www.ambu.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.